ACG New York Women of Leadership - Entrepreneur Series
Barbara Bradley Baekgaard, founder of Vera Bradley (Nasdaq: VRA), is the latest in a series of entrepreneurs highlighted at ACG New York Women of Leadership events. Photo credit: Robert Blumenfeld


GTCR, Hormel, the Riverside Co-CEOs and Others Win M&A Mid-Market Awards
Amid a slow and challenging year for dealmaking, the winners of Mergers & Acquisitions’ 7th Annual M&A Mid-Market Awards outpaced the competition to grow, innovate and lead the middle market


The Buyside:
Disney, Warner Bros. Seek Next-Gen YouTubes

Traditional Hollywood studios such as Disney and Warner Bros. are seeking next-generation YouTube content providers

The Buyside

Activist Investors Dig Into Mid Market
Spurred on by the high-profile success of Carl Icahn and others, a growing crop of firms is looking further downstream

Today's Transactions:
Covidien Acquires CV Ingenuity

CV Ingenuity is in the investigational phase of developing a drug-coated balloon product

Covidien (NYSE: COV) will acquire CV Ingenuity, a medical technology company.

Fremont, Calif.-based CV develops technology that gets rid of vascular obstructions and aims to allow vessels to heal. The company is in the investigational phases of developing a drug-coated balloon, which it expects to receive U.S. Food and Drug Administration approval in 2017. The company got more than $11 million in venture funding in November.

Covidien, headquartered in Mansfield, Mass., will incorporate CV’s business into its vascular product line. The buyer develops and manufactures medical devices, pharmaceuticals and medical supplies. Terms of the deal were not disclosed.


For more information on related topics, visit the following: